ImmuneeringIMRX
那斯達克 · USD
5.75
+0.34
(+6.28%)
收盤 04/16 03:59 (UTC+8)
04/16 03:59 (UTC+8)
ImmuneeringIMRX
5.75
+0.34
(+6.28%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 13,753 | 15,380 | 14,757 | 15,485 | 18,558 | 15,274 | - | 15,325 | 16,301 | 13,926 |
研發費用 | 9,255 | 10,868 | 10,454 | 11,472 | 14,857 | 11,253 | 10,652 | 11,202 | 11,910 | 10,050 |
推銷及管理費用 | 4,491 | 4,505 | 4,296 | 4,006 | 3,694 | 4,014 | 4,254 | 4,116 | 4,384 | 3,869 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
營業利益 | -13,753 | -15,381 | -14,758 | -15,485 | -18,558 | -15,274 | -14,914 | -15,326 | -16,302 | -13,926 |
其他收入及費用 | 2,173 | 416 | 324 | 439 | 507 | 676 | 834 | 1,018 | 1,218 | 1,331 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -11,580 | -14,965 | -14,434 | -15,046 | -18,051 | -14,597 | -14,080 | -14,308 | -15,083 | -12,595 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -11,580 | -14,965 | -14,434 | -15,046 | -18,051 | -14,597 | -14,080 | -14,308 | -15,083 | -12,595 |
基本每股稅後盈餘(元) | -0.18 | -0.38 | -0.40 | -0.42 | -0.58 | -0.49 | -0.47 | -0.49 | - | -0.43 |
稀釋每股稅後盈餘(元) | -0.07 | -0.38 | -0.40 | -0.42 | -0.59 | -0.49 | -0.47 | -0.49 | -0.52 | -0.42 |
基本平均股數(千股) | 64590.00 | 39670.00 | 35985.00 | 35529.00 | 31050.00 | 29841.00 | 29653.00 | 29370.00 | - | 29266.00 |
稀釋平均股數(千股) | 64590.00 | 39670.00 | 35985.00 | 35529.00 | 31050.00 | 29841.00 | 29653.00 | 29370.00 | - | 29266.00 |
還原基本每股稅後盈餘(元) | -0.18 | -0.38 | -0.40 | -0.42 | -0.58 | -0.49 | -0.47 | -0.49 | - | -0.43 |
還原稀釋每股稅後盈餘(元) | -0.07 | -0.38 | -0.40 | -0.42 | -0.59 | -0.49 | -0.47 | -0.49 | -0.52 | -0.42 |
還原基本平均股數(千股) | 64,590 | 39,670 | 35,985 | 35,529 | 31,050 | 29,841 | 29,653 | 29,370 | - | 29,266 |
還原稀釋平均股數(千股) | 64,590 | 39,670 | 35,985 | 35,529 | 31,050 | 29,841 | 29,653 | 29,370 | - | 29,266 |
EBITDA(千元) | -11,653 | -14,879 | -14,342 | -14,953 | -18,013 | -14,535 | -13,990 | -14,372 | -15,390 | -12,821 |